Purpose: Amide proton transfer (APT) imaging is able to extend the achievable magnetic resonance imaging (MRI) contrast to the protein level. In this study, we demonstrate the feasibility of applying a turbo-spin-echo (TSE)-based, three-dimensional (3D) APT sequence into routine clinical practice for patients with brain tumors. Procedures: Experiments were performed on a Philips 3-Tesla (3-T) MRI scanner using an eightchannel phased-array coil for reception. A fast 3D APT sequence with a TSE acquisition was proposed (saturation power, 2 μT; saturation time, 500 ms; 8 slices). The gradient echo (GRE)-based field-mapping technique or water-saturation-shift-referencing (WASSR) technique was used to acquire B 0 maps to correct for B 0 -induced artifacts in APT images. The test was performed on a box of homogenous protein solution, four healthy volunteers, and eight patients with high-grade gliomas. Results: The experimental data from a homogenous, protein-containing phantom and healthy volunteers show that the sequence produced a uniform contrast across all slices. The average MTR asym (3.5 ppm) values with GRE B 0 -corrected 3D APT imaging and WASSR-corrected 3D APT imaging were both comparable to the values obtained using the undemanding single-slice acquisition. The average APT image intensity was consistently higher in the tumor core than in the peripheral edema and in the contralateral normal-appearing white matter (both PG0.001). Conclusion: 3D APT imaging of brain tumors can be performed in about 5 min at 3-T using a routine, commercial eight-channel SENSE coil.
Introduction

P
roteins are the most essential parts of organisms and perform almost all cellular activities. However, these molecules cannot be detected directly by magnetic resonance (MR) imaging due to the low concentration or because of limited motion in tissue. The amide protons of mobile proteins, such as those in the cytoplasm, resonate at 8.3 ppm of the proton MR spectrum [1] , namely, 3.5 ppm downfield of the water signal. There is an exchange between the amide protons of mobile proteins and the protons of bulk water, and the exchange rate is 20-30 Hz in vivo [2] , which is favorable for MR detection. Chemical exchange-dependent saturation transfer (CEST) imaging [3] [4] [5] [6] [7] , a type of wellknown magnetization transfer (MT) imaging [8] , provides the possibility to spatially assess these mobile proteins in vivo, indirectly. Technically, these amide protons are selectively saturated, and the saturation is then transferred to the water protons. This process repeats itself and finally decreases the water signal intensity significantly. Because of the sensitivity enhancement with CEST, endogenous mobile proteins [9] can be assessed indirectly via the water signal. This technique is called amide proton transfer (APT) imaging [2, 10, 11] .
APT imaging has been successfully applied to brain tumor [12] [13] [14] and stroke [15] patients at 3-Tesla (3-T), but these clinical applications are mainly limited to a single-slice acquisition, due to several technical limitations, such as high radiofrequency (RF) power deposition and the long scan time required for multiple acquisitions at different frequencies. Recently, several volumetric APT imaging techniques were proposed [16] [17] [18] [19] [20] [21] . For example, Sun et al. [16] reported a multi-slice APT imaging technique in an animal system. This technique obtained a five-slice acquisition after the completion of a single long RF irradiation and then compensated the relaxation loss between earlier and later slices with the post-processing method. Dixon et al. [17] reported another multi-slice gradient-echo CEST imaging method at 1.5-T. The sequence was composed of several interleaved, short pre-saturation pulses and spatially selective observation pulses, and five slices were acquired. Notably, Zhu et al. [18] developed a fast, three-dimensional (3D) whole-brain CEST technique at 3-T. The sequence used a gradient-and spin-echo (GRASE) readout, with an asymmetric frequency-modulated pulse to suppress the lipid signal and a 32-channel phased-array coil to achieve a sensitivity-encoding (SENSE) acceleration factor of four. Jones et al. [21] reported another fast, 3D whole-brain, steady-state CEST sequence at 7-T. The sequence consisted of numerous brief saturation pulses, each followed by a segmented echo-planar imaging (EPI) acquisition. Compared with the multi-slice imaging, the 3D acquisition is preferred for volume APT imaging because of its minimized relaxation loss between slices, large volume coverage, high signal-to-noise ratio, and reasonable acquisition time [18] .
In this study, we present a 3D APT imaging sequence using the turbo-spin-echo (TSE) acquisition that is based on the routine eight-channel SENSE coil. Clinical applications are demonstrated through the imaging of brain tumors.
Materials and Methods
Phantoms and Human Subjects
In phantom experiments, a box of homogenous bovine serum albumin (BSA) solution (10 % protein concentration) was used. In human studies, four healthy volunteers (three males, one female; age range, 20-46 years; mean, 34.2 years) and eight patients (six males, two females; age range, 7-55 years; mean, 29.6 years; see Table 1 for patient information in more detail) with high-grade brain tumors were investigated. The study protocol was approved by the local Institutional Review Board. All volunteers and patients provided written, informed consent.
MRI Protocol
Experiments were performed on a Philips 3-T magnetic resonance imaging (MRI) scanner (Achieva 3.0-T; Philips Healthcare Systems, Best, The Netherlands) equipped with a pencil-beam, secondorder shim, using a body coil for RF transmission and an eightchannel SENSE coil for reception.
In the 3D APT imaging experiments, an off-resonance long RF saturation pulse with a duration of 500 ms (which is the longest allowed for our body coil) and a power level of 2 μT (which was optimized in our recent study [15] ) was used. Multiple frequency offsets (M 0 , ±3, ±3.5 [2] , and ±4 ppm; the values in brackets were the number of acquisitions, which was 1, if not specified) were acquired. Other imaging parameters for 3D volumetric APT imaging were: TSE readout; TSE factor054; SENSE factor01.7; repetition time (TR)02,500 ms; echo time (TE)011 ms; matrix0 128×64; field of view0240×240 mm 2 ; 8 slices or points; thickness or resolution06.0 mm; scan time05.3 min. Two B 0 field-mapping methods were used for comparison. One was the gradient echo (GRE)-based field-mapping method, and the other was the so-called water-saturation-shift-referencing method (WASSR) [22] . For the former, a 3D T 1 fast-field-echo sequence was used (TR030 ms). Five phase images, with TEs of 1.28, 2.28, 3.28, 4.28, and 5.28 ms, were acquired to obtain a B 0 map. For the latter, an RF saturation sequence with a low B 1 (0.2 μT) and a short time (100 ms) was used, and the data were acquired with a multi-offset scheme (0, ±12, ±24, ±36, ±48, ±60, ±72, ±84, ±96, and ±108 Hz; 1 ppm0 128 Hz at 3-T). These two B 0 field methods took 23 s and 1.7 min, respectively. To ensure the same B 0 fields for the B 0 scans and APT scans, the f 0 determination and shimming functions were turned off during the prescan of the field-mapping acquisitions (after the APT image data were acquired). The specific absorption rate (SAR) was 2.7 W/kg for the 3D APT imaging scan; 1.0 W/kg for the GRE B 0 scan; and 0.3 W/kg for the WASSR B 0 scan; all of which were within the FDA guidelines (3 W/kg averaged over the head for any 10-min period).
Single-slice APT imaging was acquired for comparison. The single-slice acquisition protocol proposed previously [14] was used, in which the APT image scan and z-spectrum scan were combined (31 offsets00, ±0.25, ±0.5, ±0.75, ±1, ±1.5, ±2, ±2.5, ±3 [2] , ±3.25 [4] , ±3.5 [8] , ±3.75 [4] , ±4 [2] , ±4.5, ±5, and ±6 ppm; an unsaturated image was acquired for the signal normalization). Other single-slice imaging parameters were: single-shot TSE readout; TSE factor042; SENSE factor01.7; TR02,500 ms; TE011 ms; matrix 0128× 64; field of view 0240 ×240 mm 2 ; scan time0 2.7 min; and SAR01.3 W/kg.
For reference, several standard MR images, including T 2 -weighted, T 1 -weighted, fluid-attenuated inversion recovery (FLAIR), and gadolinium (Gd)-enhanced T 1 -weighted, were acquired. The parameters used were: T 2 -weighted (TSE factor08, TR/ TE03,000/80 ms, 18 slices, thickness06.0 mm, sense factor01.6); T 1 -weighted (3D magnetization-prepared-rapid-gradient-echo sequence, TR/TE/TI02,000/20/800 ms, 18 slices, thickness06.0 mm, SENSE factor01.6); FLAIR (TSE factor027, TR/TE/TI011,000/ 125/2,800 ms, 18 slices, sense factor01.6); and Gd-enhanced T 1 -weighted (single-shot turbo field echo, flip angle015°, TR/TE0 15/4.6 ms, thickness06.0 mm, SENSE factor01.6). The APT images were acquired before the administration of the Gd contrast agent.
Theory
The APT effect reflects the cellular protein information in the biological tissue but contains the concurrent saturation effects, such as conventional MT and direct water saturation. The MT ratio (MTR) is defined as 1−S sat /S 0 , where S sat and S 0 are the signal intensities with and without selective irradiation, respectively. In order to remove these unwanted contributions, the asymmetry analysis of MTR with respect to the water frequency is generally used:
For APT imaging, the asymmetry analysis at 3.5 ppm downfield from the water signal is calculated as [2, 10, 11] :
where MTR 0 asym (3.5 ppm) is the inherent asymmetry of the conventional MT effect associated with immobile macromolecules and membranes (which is usually negative) [23] , and APTR is the proton transfer ratio for the amide protons. Although the asymmetry analysis was performed, a small, residual MTR asymmetry still exists. This is because the conventional MT effect is not absolutely symmetric with respect to water in vivo, which contributes a negative background signal. Thus, the measured MTR asym (3.5 ppm) is just an apparent APT signal, and the calculated MTR asym (3.5 ppm) images should be called APT-weighted images and APT images (for simplicity).
The APT images were susceptible to B 0 inhomogeneity, although the pencil-beam shimming was employed, and these images have to be corrected according to the B 0 field information. Three APT images with the different B 0 corrections were compared in this study: single-slice APT; GRE B 0 -corrected 3D APT; and WASSR-corrected 3D APT.
Data Analysis
All data processing procedures were performed using the interactive data language (IDL, version 7; Exelis Visual Information Solutions, Inc., Boulder, CO). For the single-slice APT imaging, a full z-spectrum (S sat /S 0 as a function of frequency offset relative to water) was fitted through 31 offsets using a 12th-order polynomial (the maximum order available with IDL) on a voxel-by-voxel basis. The fitted curve was interpolated using an offset resolution of 1 Hz. The corresponding B 0 field inhomogeneity was calculated according to the deviation of the minimum of the fitted curve from 0 ppm, and the measured z-spectrum for each voxel was shifted along the direction of the offset axis accordingly. Then, the realigned z-spectra were interpolated back to 31 points, and the MTR asym (3.5 ppm) image was calculated.
The 3D APT data were processed with two different methods. For the GRE B 0 -corrected 3D APT images, the B 0 map was first fitted from the five phase images (TE01.28, 2.28, 3.28, 4.28, and 5.28 ms). For the WASSR-corrected 3D APT images, a z-spectrum, dominated by direct water saturation, was fitted though 19 offsets, using a 12th-order polynomial on a voxel-by-voxel basis. The fitted curve was interpolated using an offset resolution of 1 Hz. The water center frequency in each voxel was determined by the minimum of the fitted curve from 0 ppm accordingly. Then, to correct for the field inhomogeneity effects in the APT images, the acquired APT data at offsets (+4, +3.5, +3 ppm) for each voxel were interpolated to 257 points, over a range from +4.5 to +2.5 ppm (1 Hz resolution), and shifted using the B 0 value for the same voxel. A similar procedure was applied to the negative-offset data (−3, −3.5, −4 ppm). Finally, the corrected APT images with two different B 0 maps, the GRE B 0 -corrected 3D APT images and the WASSRcorrected 3D APT images, were calculated using the shiftcorrected data at ±3.5 ppm. All APT images were thresholded, based on the signal intensity of the S 0 image, to remove voxels outside the brain.
For the quantitative analysis, regions of interest were chosen by two experienced radiologists (ZW and XW, who had ∼20 and 10 years of experience in brain tumor imaging, respectively). For normal brain tissues, regions of interest were drawn on relatively homogenous white matter. For brain tumors, the regions of interest were placed according to the signal abnormalities on the Gd-enhanced, T 1 -weighted and other MR images, with the support of the histopathological findings. The contralateral normal-appearing white matter was also chosen for reference. All results were expressed as mean±standard deviation. A oneway analysis of variance test, followed by multiple comparisons 
Results
Single-Slice and 3D APT Experiments on a Phantom Fig. 1 shows the z-spectrum and MTR asym (3.5 ppm) results acquired using the 3D TSE APT imaging sequence and the single-slice APT imaging sequence (repeated single-slice APT) on a phantom of homogeneous BSA solution with a 10 % protein concentration. The experimental data show that the average MTR asym (3.5 ppm) values across eight slices for both GRE B 0 -corrected 3D APT imaging and WASSRcorrected 3D APT imaging were comparable with those of repeated single-slice APT imaging. In addition, for GRE B 0 -corrected 3D APT and WASSR-corrected 3D APT, the average MTR asym (3.5 ppm) values did not vary obviously, and there was no visual signal loss due to T 1 relaxation in 3D acquisition across slices, as expected.
Single-Slice and 3D APT Experiments on Normal Subjects
Fig . 2 shows the T 2 -weighted image, B 0 maps from the singleslice APT, multiple GRE and WASSR scans, and the MTR asym (3.5 ppm) image without the B 0 inhomogeneity correction. Also displayed in Fig. 2 are the MTR asym (3.5 ppm) images using the single-slice technique, the GRE B 0 -corrected 3D APT approach, and the WASSR-corrected 3D APT approach, all of which were obtained from a typical normal subject. Although the higher-order shimming was employed, the serious magnetic field inhomogeneity-related artifacts were still seen in the acquired (uncorrected) APT image (Fig. 2e) . The appropriate B 0 field inhomogeneity corrections were required. For the 3D APT imaging, we acquired two B 0 field maps (Fig. 2c, d ) under the same shimming conditions as the 3D APT imaging scan. The B 0 field inhomogeneity as seen in the maps was typically less than 20 Hz in the relevant brain regions but could be more than 100 Hz near air-tissue interfaces (sinus, ear). The variation between these two B 0 maps was less than 5 Hz in most brain areas. In the corrected MTR asym (3.5 ppm) images, including the single-slice APT, the GRE B 0 -corrected 3D APT, and the WASSR-corrected 3D APT, the artifacts that resulted from the B 0 field inhomogeneity were virtually absent, and the APT images were homogenous in most brain regions. 3D APT methods from healthy volunteers (n04). The singleslice acquisition was localized at slice 6 from the 3D sequence. For both GRE B 0 -corrected 3D APT and WASSR-corrected 3D APT, the MTR asym (3.5 ppm) images show relative homogeneity in all slices, and no large B 0 field inhomogeneity artifacts were seen. The measured average MTR asym (3.5 ppm) data from both 3D approaches were nearly constant across all slices. For slice 6, the measured MTR asym (3.5 ppm) from GRE B 0 -corrected 3D APT and WASSR-corrected 3D APT images was 0.14 %±0.18 % and 0.30 %±0.21 %, respectively, which were very close to the single-slice APT value (0.22 %±0.16 %). Note that the measured MTR asym (3.5 ppm) values were almost zero, because the MTR 0 asym (3.5 ppm) (which is negative) and APTR (which is positive) nearly canceled each other out at 2 μT, as reported in our previous study [15] . (Fig. 4b) , was consistent with the area of hyperintensity in the APT images (Fig. 4c) . The APT hyperintensity (compared with the contralateral white matter) is a typical feature of high-grade (grade III and IV) brain tumors, in line with expectations based on the increased content of cellular proteins in lesions. The surrounding peritumoral edema that was hyperintense on T 2 -weighted images exhibited isointensity (relative to the contralateral normal-appearing white matter) on the APT images. For the same slice, the Fig. 4 . MR images for a patient (patient 8) with glioblastoma. a T 2 -weighted images show a heterogeneous tumor mass. b Gdenhanced, T 1 -weighted images demonstrate heterogeneous enhancement (red arrow) with some non-enhancing necrotic areas (pink arrow). c APT images (WASSR-corrected) show that the Gd-enhancing tumor core is hyperintense, while the necrotic region and the surrounding edematous area (orange arrow) are both hypointense. d Single-slice APT image corresponding to the third slice of (c). e GRE B 0 -corrected 3D APT image corresponding to the third slice of (c). f, g Histopathological sections sampled from the tumor core and necrotic area, respectively. Red arrowhead: irregular tumor cells; blue arrowhead: "false fence" necrosis.
Single-Slice and 3D APT Experiments on Patients with High-Grade Brain Tumors
tumor appearance on the GRE B 0 -corrected APT image or on the WASSR-corrected APT image was comparable to the appearance on the single-slice APT image. The specimens were sampled from the tumor core and necrotic areas, respectively. The tumor core showed histopathological characteristics with abundant irregular tumor cells (Fig. 4f) and "false fence" necrosis ( Fig. 4g) . Fig. 5 shows the standard and APT images from a patient with a grade-III astrocytoma (patient 3) in the right parietal lobe. In this case, there is no obvious signal enhancement in the Gd-enhanced T 1 -weighted image. However, the markedly elevated APT signal intensity is still visible within the T 2 -hyperintense lesion. The region with high APT signal was sampled during the clinical surgical procedure. The histopathological exam shows high tumor cellularity, no necrosis, and little vascular proliferation. The result confirms the radiological diagnosis of grade-III astrocytoma. This case illustrates that APT images can provide additional information about the presence and grade of brain tumors, especially when Gd enhancement is not available. Table 2 shows the MTR asym (3.5 ppm) values for the same slice measured with three different B 0 correction methods, single-slice APT, GRE B 0 -corrected 3D APT, and WASSRcorrected 3D APT. For the tumor core, peritumoral edema, or contralateral brain tissue, the measured MTR asym (3.5 ppm) values were comparable, and there were no significant differences between the values for the different methods (P90.2). For all gliomas, the average MTR asym (3.5 ppm) values were significantly higher in the tumor core than in the peritumoral edema and in the contralateral brain tissue (both PG0.001).
Discussion
APT imaging is a novel molecular MRI method and has drawn considerable attention recently [24] [25] [26] [27] [28] [29] . However, several issues must be considered to obtain a good APT contrast. First, to maximize the APT signal for the lowconcentration (micromolar to millimolar) cellular mobile proteins, a long, low-power RF irradiation pulse or an RF pulse-train scheme is required. Second, a sufficient signal-tonoise ratio is always required, which may require multiple acquisitions for averaging. Third, according to the RF radiation power dependence properties of the APT signal, an appropriate RF irradiation power should be selected. Last, but not least, some attention should be paid to the B 0 inhomogeneity that may cause a significant artifact in APT images. Thus, it is necessary to develop some methods to correct for local frequency shifts. When APT imaging was translated to the clinic, more problems have to be solved, such as the large volume coverage, feasible scan times, permissible RF power deposition, etc. Recently, several high-quality clinical results from the application of APT imaging have been reported [14, 15] . However, these clinical studies were mainly restricted to a single-slice acquisition, as the acquisition schemes acquired a full z-spectrum with about 30 frequency offsets and were time-consuming.
To improve the clinical significance, volumetric APT imaging should be developed. Technically, it would be desirable to design a 3D APT imaging sequence that provides enough imaging coverage as well as good contrast. Moreover, this 3D APT acquisition should not require a long scan time to avoid possible motion artifacts. Practically, it is better that a routine MRI coil, such as the eight-channel SENSE coil, should be used, which will help to extend the clinical application of the APT technique. In the proton MR spectrum, the lipid protons resonate at 1.3 ppm, and the amide protons appear at around 8.3 ppm. Their chemical shift differences from water (4.7 ppm) are almost the same, but of opposite sign. This would lead to the extra saturation of lipid protons in the reference scan [S sat (−3.5 ppm)], but not in the APT scan [S sat (3.5 ppm)], thus incurring a lipid artifact when the asymmetry analysis is used. To hasten the 3D acquisition, a rapid acquisition technique, such as EPI, TSE, or GRASE, is preferred. Our experience shows that EPI or GRASE may bring about more serious lipid artifacts [18] , compared with the TSE acquisition, especially when a 32-channel phased-array coil is used. The TSE sequence was used for the 3D APT acquisition in this study because of its high image quality and fewer lipid artifacts. Although the TSE acquisition suffered from a relatively high SAR, our experimental results showed that the SAR was still within the FDA limitations.
The B 0 field inhomogeneity maps can be obtained quickly by the GRE-based field-mapping and the WASSR methods [22] . Based on these, we proposed two 3D volumetric APT imaging schemes (GRE B 0 -corrected 3D APT and WASSR-corrected 3D APT) that can be used in any standard clinical 3-T setting. Notably, the APT imaging scan time is only about 5 min. Such fast volumetric APT imaging techniques should be particularly useful in the clinic. In this work, we paid more attention to the feasibility analysis of these fast 3D schemes. In the phantom and normal volunteer studies, we found that the measured MTR asym (3.5 ppm) value for each slice using the 3D APT acquisitions was comparable to the value for the corresponding slice using the single-slice APT acquisition. Moreover, these values do not vary across the slices obviously. The results demonstrated that both 3D APT experimental schemes can offer experimental results similar to those of the single-slice APT scheme. In addition, both 3D APT schemes can remove most artifacts caused by the B 0 inhomogeneity, just as the single-slice APT did. Quantitatively, the MTR asym (3.5 ppm) values in several regions were compared for the three experimental methods ( Table 2 ). The results show that these three B 0 correction methods gave comparable MTR asym (3.5 ppm) results.
Our 3D APT acquisition schemes can provide good clinical experimental results for brain tumors and do not require any special hardware or software but can offer more information about lesions. Just as with our previous singleslice-based experimental results [12] [13] [14] , the addition of 3D APT imaging to the standard MRI protocol may help distinguish the heterogeneity of a malignant brain tumor, and these capabilities of APT imaging may be very important in the diagnosis and treatment planning for patients with brain tumors.
Conclusions
We have developed and validated a 3D APT imaging experimental scheme, at 3-T, that uses a standard, commercial eight-channel SENSE coil for reception. The technique uses the GRE field-mapping method or the WASSR method to obtain B 0 -corrected 3D volumetric APT images in about 5 min. Our experimental results showed that this 3D APT sequence with the TSE acquisition can provide good image quality and enough volume coverage for clinical applications, such as for the imaging of brain tumors. The early results suggest that 3D APT may be a valuable addition to the MRI armamentarium for the accurate characterization of human brain tumors. 
